Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 376

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Addressing overtreatment of screen detected DCIS; the LORIS trial

Open access
Francis, Adele, Thomas, Jeremy, Fallowfield, Lesley, Wallis, Matthew, Bartlett, John M.S., Brookes, Cassandra, Roberts, Tracy, Pirrie, Sarah, Gaunt, Claire, Young, Jennie, Billingham, Lucinda, Dodwell, David, Hanby, Andrew, Pinder, Sarah E., Evans, Andrew, Reed, Malcolm, Jenkins, Valerie, Matthews, Lucy, Wilcox, Maggie, Fairbrother, Patricia, Bowden, Sarah, Rea, Daniel·2015·European Journal of Cancer

Abstract

Overdiagnosis, and thus overtreatment, are inevitable consequences of most screening programmes; identification of ways of minimising the impact of overdiagnosis demands new prospective research, in particular the need to separate clinically relevant lesions that require active treatment from those that can be safely left alone or monitored and only need treated if they change characteristics. Breast cancer screening has led to a large increase in ductal carcinoma in situ (DCIS) diagnoses. This is a widely heterogeneous disease and most DCIS detected through screening is of high cytonuclear grade and therefore likely to be important clinically. However, the historic practice of surgical treatment for all DCIS is unlikely to be optimal for lower risk patients. A clearer understanding of how to manage DCIS is required. This article describes the background and development of 'The low risk' DCIS trial (LORIS), a phase III trial of surgery versus active monitoring. LORIS will determine if it is appropriate to manage women with screen detected or asymptomatic, low grade and intermediate grade DCIS with low grade features, by active monitoring rather than by surgical treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2015.07.017

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 376

Metadata

Authors
Francis, A., Thomas, J., Fallowfield, L., Wallis, M., Bartlett, J. M. S., Brookes, C., Roberts, T., Pirrie, S., Gaunt, C., Young, J., Billingham, L., Dodwell, D., Hanby, A., Pinder, S. E., Evans, A., Reed, M., Jenkins, V., Matthews, L., Wilcox, M., Fairbrother, P., Bowden, S., & Rea, D.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2015-11
Volume
51
Issue
16
Pages
2296-2303
ISSN
0959-8049 (ISSN-L)
OpenAlex
W2119349383
Cited by
376
References
16
FWCI
9.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Addressing overtreatment of screen detected DCIS; the LORIS trial. https://app.cochat.ai/papers/10.1016/j.ejca.2015.07.017
The paper
Francis, A., Thomas, J., Fallowfield, L., Wallis, M., Bartlett, J. M. S., Brookes, C., Roberts, T., Pirrie, S., Gaunt, C., Young, J., Billingham, L., Dodwell, D., Hanby, A., Pinder, S. E., Evans, A., Reed, M., Jenkins, V., Matthews, L., Wilcox, M., . . . Rea, D. (2015). Addressing overtreatment of screen detected DCIS; the LORIS trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2015.07.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.